Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126037751 | 12603775 | 1 | I | 2010 | 20160106 | 20160728 | 20160728 | PER | US-MYLANLABS-2016M1002611 | MYLAN | 0.00 | M | Y | 0.00000 | 20160728 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126037751 | 12603775 | 1 | PS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | 76187 | TABLET | |||||||||||
126037751 | 12603775 | 2 | SS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | 76187 | TABLET | |||||||||||
126037751 | 12603775 | 3 | SS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | 76187 | TABLET | |||||||||||
126037751 | 12603775 | 4 | SS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | 76187 | TABLET | |||||||||||
126037751 | 12603775 | 5 | SS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | 76187 | TABLET | |||||||||||
126037751 | 12603775 | 6 | SS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | 76187 | TABLET |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126037751 | 12603775 | Exposure via skin contact | |
126037751 | 12603775 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |